Xanthelasma

Source: Wikipedia, the free encyclopedia.
Xanthelasma
Other namesxanthelasma palpebrarum; xanthoma palpebrarum
Pronunciation
SpecialtyOphthalmology Edit this on Wikidata

Xanthelasma is a sharply demarcated yellowish deposit of

eyelids (xanthelasma palpebrarum, abbreviated XP).[1][2] While they are neither harmful to the skin nor painful, these minor growths may be disfiguring and can be removed.[1] There is a growing body of evidence for the association between xanthelasma deposits and blood low-density lipoprotein levels and increased risk of atherosclerosis.[3][4]

A xanthelasma may be referred to as a xanthoma when becoming larger and nodular, assuming tumorous proportions.[5] Xanthelasma is often classified simply as a subtype of xanthoma.[6]

Diagnosis

Xanthelasma in the form of XP can be diagnosed from clinical impression, although in some cases it may need to be distinguished (

medial side of the upper eyelids; sometimes the lower eyelids are affected as well.[2]

Treatment

Xanthelasmata can be removed with a trichloroacetic acid peel, surgery, lasers or cryotherapy.[2] Removal may cause, although uncommon, scarring and pigment changes.

Prognosis

Recurrence is common: 40% of patients with XP had recurrence after primary surgical excision, 60% after secondary excision, and 80% when all four eyelids were involved. A possible cause might be insufficiently deep excisions.[2]

Epidemiology

Xanthelasma is a rare disorder in the general population, with a variable incidence of 0.56 to 1.5% in western developed countries. The age of onset ranges from 15 to 75, with a peak in the 4th to 5th decades of life. There also seems to be a greater prevalence in females, but this might be due to higher consciousness to cosmetic defects.[7]

Etymology

The word is derived from Greek xanthós, ξανθός 'yellow' and élasma, έλασμα, 'foil'. The plural is xanthelasmata.

See also

References

  1. ^ a b c Frew JW, Murrell DF, Haber RM (October 2015). "Fifty shades of yellow: a review of the xanthodermatoses". International Journal of Dermatology. 54 (10): 1109–1123.
    PMID 26227781
    .
  2. ^ .
  3. ^ Ozdöl S, Sahin S, Tokgözoğlu L (August 2008). "Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a)". International Journal of Dermatology. 47 (8): 785–9.
    S2CID 25746456
    .
  4. ^ Chang, Hua-Ching; Sung, Chih-Wei; Lin, Ming-Hsiu (March 2020). "Serum lipids and risk of atherosclerosis in xanthelasma palpebrarum: A systematic review and meta-analysis". Journal of the American Academy of Dermatology. 82 (3): 596–605.
    S2CID 202413378
    .
  5. ^ Shields C, Shields J (2008). Eyelid, conjunctival and orbital tumors: atlas and textbook. Hagerstwon, MD: Lippincott Williams & Wilkins. ]
  6. ^ Xanthelasma (8th ed.). 2009. Retrieved November 8, 2012. {{cite book}}: |work= ignored (help)
  7. PMID 23105704
    .

External links